European equities traded in the US as American depositary receipts were falling sharply late Thursday morning, down 1.78% to 1,777.91 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and consumer goods company Unilever (UL), which rose 2.7% and 1%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and telecommunications company Nokia (NOK), which were up 0.6% and 0.4%, respectively.

The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria (BBVA) and semiconductor company Sequans Communications (SQNS), which fell 6.8% and 6.7%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Grifols (GRFS), which lost 6.6% and 4.2%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which climbed 10% and 4.9%, respectively. They were followed by pharmaceutical companies GSK (GSK) and AstraZeneca (AZN), which advanced 2.8% and 1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 7.2% and 7%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and telecommunications operator Vodafone Group (VOD), which were down 5.9% each.